HALOBETASOL for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 209 adverse event reports in the FDA FAERS database where HALOBETASOL was used for Psoriasis.
Most Reported Side Effects for HALOBETASOL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 207 | 49.5% | 0 | 6 |
| Psoriasis | 85 | 20.3% | 0 | 1 |
| Product use in unapproved indication | 59 | 14.1% | 0 | 0 |
| Therapeutic product effect incomplete | 43 | 10.3% | 0 | 0 |
| Treatment failure | 41 | 9.8% | 0 | 0 |
| Pruritus | 34 | 8.1% | 0 | 1 |
| Condition aggravated | 29 | 6.9% | 0 | 0 |
| Rash | 28 | 6.7% | 0 | 2 |
| Skin exfoliation | 28 | 6.7% | 0 | 2 |
| Off label use | 27 | 6.5% | 0 | 0 |
| Erythema | 26 | 6.2% | 0 | 2 |
| Arthralgia | 24 | 5.7% | 0 | 1 |
| Cough | 20 | 4.8% | 0 | 0 |
| Skin lesion | 20 | 4.8% | 0 | 1 |
| Pain in extremity | 19 | 4.6% | 0 | 5 |
Other Indications for HALOBETASOL
Product used for unknown indication (96)
Pruritus (13)
Rash (11)
Psoriatic arthropathy (10)
Eczema (7)
Hidradenitis (7)
Lichen sclerosus (7)
Dyshidrotic eczema (6)
Dermatitis atopic (5)
Lichenoid keratosis (5)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)